CryoLife Reports Record Quarterly Revenues of $28...(isitions of products or distribution rig...),Health

Date:7/30/2009

isitions of products or distribution rights may not be successful, if we are not successful in expanding our business activities in international markets, we will be unable to pursue one of our strategies for increasing our revenues, continued deflation of foreign currencies relative to the U.S. dollar could materially and adversely impact our business, and future healthcare policies, healthcare reimbursement methods, and healthcare reimbursement policies may affect the availability, amount, and timing of our revenues, financial condition and profitability. These risks and uncertainties include the risk factors detailed in our Securities and Exchange Commission filings, including our Form 10-K filing for the year ended December 31, 2008, our Form 10Q filing for the quarter ended March 31, 2009, our Form 10-Q to be filed for the quarter ended June 30, 2009, and the Company's other SEC filings. The Company does not undertake to update its forward-looking statements.

                        CRYOLIFE, INC. AND SUBSIDIARIES
                              Financial Highlights
                     (In thousands, except per share data)


                                        Three Months Ended   Six Months Ended
                                              June 30,           June 30,
                                        ------------------   ----------------
                                          2009     2008       2009     2008
                                        ------------------   ----------------
                                           (Unaudited)        (Unaudited)
    Revenues:
      Preservation services              $14,091   $13,725   $27,639  $27,149
      Products                            13,918    13,280    26,863   25,260
      Other                                  154       150       349      314
                                        ------------------   ----------------
 
'/>"/>
SOURCE  CryoLife, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Related medicine news :

1. CryoLife Announces Release Date and Teleconference Call Details for 2009 Second Quarter Financial Results
2. Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology
3. CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2008 Financial Results
4. William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education
5. Cryolife Victim Responds to Untrue Assertions of Cryolife
6. CryoLife Announces Additions to Management Team
7. Gentiva Reports Second Quarter 2009 Results
8. BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
9. Encision Reports Profitable First Fiscal Quarter Results
10. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
11. Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share